Predictors of suboptimal glycaemic control in type 2 diabetes patients: The role of medication adherence and body mass index in the relationship between glycaemia and age

Diabetes Research and Clinical Practice

Volumn 96, Issue 2, 2012, Pages 119-128

  Nagrebetsky, Alexander ^a   Griffin, Simon ^b   Kinmonth, Ann Louise ^c   Sutton, Stephen ^c   Craven, Anthea ^a   Farmer, Andrew ^a,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d University of Manchester   (United Kingdom)

Author keywords

Adherence; Glycaemic control; Predictors; Primary care; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; METFORMIN;

ADULT; AGE; ARTICLE; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREDICTION;

AGE FACTORS; AGED; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED;

EID: 84860533869     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.12.003     Document Type: Article

References (39)

1. Stratton I.M., Kohner E.M., Aldington S.J., Turner R.C., Holman R.R., Manley S.E., et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001, 2:156-163.
2. Stratton I.M., Adler A.I., Neil A.W., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 405-412.
3. Adler A.I., Boyko E.J., Ahroni J.H., Stensel V., Forsberg R.C., Smith D.G. Risk factors for diabetic peripheral sensory neuropathy: results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 1997, 7:1162-1167.
4. UK Prospective Diabetes Study (UKPDS). X. Urinary albumin excretion over 3 years in diet-treated type 2 (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia. Diabetologia 1993, 10:1021-1029.
5. Ballard D.J., Humphrey L.L., Melton L.J., Frohnert P.P., Chu P.C., O'Fallon W.M., et al. Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 1988, 4:405-412.
6. National Collaborating Centre for Chronic Conditions Type 2 diabetes: national clinical guideline for management in primary and secondary care (update) 2008, Royal College of Physicians, London.
7. American Diabetes Association Standards of medical care in diabetes-2011. Diabetes Care 2011, S11-S61.
8. Currie C.J., Gale E.A., Poole C.D. Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007. Diabet Med 2010, 8:938-948.
9. Nathan D.M. Finding new treatments for diabetes - how many, how fast... how good?. N Engl J Med 2007, 5:437-440.
10. Calvert M.J., McManus R.J., Freemantle N. The management of people with type 2 diabetes with hypoglycaemic agents in primary care: retrospective cohort study. Fam Pract 2007, 3:224-229.
11. Janghorban M., Amini M. Predictors of switching to insulin from non-insulin therapy in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2011, 1:111-117.
12. Chiu C.J., Wray L.A. Factors predicting glycemic control in middle-aged and older adults with type 2 diabetes. Prev Chronic Dis 2010, 1:A08.
13. Tokuyama Y., Ishizuka T., Matsui K., Egashira T., Kanatsuka A. Predictors of glycemic control in Japanese subjects with type 2 diabetes mellitus. Metabolism 2008, 4:453-457.
14. Kong W., Langlois M.F., Kamga-Ngande C., Gagnon C., Brown C., Baillargeon J.P. Predictors of success to weight-loss intervention program in individuals at high risk for type 2 diabetes. Diabetes Res Clin Pract 2010, 2:147-153.
15. Turner R.C., Cull C.A., Frighi V., Holman R.R. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999, 21:2005-2012.
16. Olivarius Nde F., Siersma V., Hansen L.J., Drivsholm T., Horder M. Changes in levels of haemoglobin A1c during the first 6 years after diagnosis of clinical type 2 diabetes. Scand J Clin Lab Invest 2009, 8:851-857.
17. Benoit S.R., Fleming R., Philis-Tsimikas A., Ji M. Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study. BMC Public Health 2005, 36.
18. El-Kebbi I.M., Ziemer D.C., Cook C.B., Miller C.D., Gallina D.L., Phillips L.S. Comorbidity and glycemic control in patients with type 2 diabetes. Arch Intern Med 2001, 10:1295-1300.
19. Hu D., Henderson J.A., Welty T.K., Lee E.T., Jablonski K.A., Magee M.F., et al. Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study. Diabetes Care 1999, 11:1802-1807.
20. Wedick N.M., Barrett-Connor E., Knoke J.D., Wingard D.L. The relationship between weight loss and all-cause mortality in older men and women with and without diabetes mellitus: the Rancho Bernardo study. J Am Geriatr Soc 2002, 11:1810-1815.
21. Lehmann A.B., Bassey E.J. Longitudinal weight changes over four years and associated health factors in 629 men and women aged over 65. Eur J Clin Nutr 1996, 1:6-11.
22. Farmer A.J., Prevost A.T., Hardeman W., Craven A., Sutton S., Griffin S.J., et al. Protocol for SAMS (Support and Advice for Medication Study): a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication. BMC Fam Pract 2008, 20.
23. Noble M., Wright G., Dibben C., Smith G.A.N., McLennan D., Anttila C., et al. Indices of deprivation 2004. Report to the Office of the Deputy Prime Minister 2004, Neighbourhood Renewal Unit, London.
24. Horne R. Non-adherence to medication: causes and implications for care. A behavioural approach to pharmacy practice 2001, 111-130. Blackwell, Oxford. P. Gard (Ed.).
25. Ware J., Kosinski M., Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 3:220-233.
26. Farmer A.J., Prevost A.T., Griffin S.J., Hardeman W., Sutton S., Kinmonth A.-L. Impact of a theory-based intervention to support medication adherence for patients with type 2 diabetes: an Open Parallel Group Randomized Trial. Late breaking presentation. American Diabetes Association annual meeting 2008.
27. Nagrebetsky A., Griffin S.J., Kinmonth A.L., Craven A., Farmer A.J. Predictors of glycaemic outcomes in primary care patients with uncontrolled diabetes: a prospective cohort analysis. Diabet Med 2011, 84-85. [Abstract].
28. Goudswaard A.N., Stolk R.P., Zuithoff P., Rutten G.E. Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care. Eur J Epidemiol 2004, 6:541-545.
29. Nichols G.A., Hillier T.A., Javor K., Brown J.B. Predictors of glycemic control in insulin-using adults with type 2 diabetes. Diabetes Care 2000, 3:273-277.
30. Ben Abdelaziz A., Soltane I., Gaha K., Thabet H., Tlili H., Ghannem H. Predictive factors of glycemic control in type 2 diabetes mellitus patients in primary health care. Rev Epidemiol Sante Publique 2006, 5:443-452.
31. 1c value. Br J Gen Pract 2003, 490:389-391.
32. Blumenthal K.J., Larkin M.E., Winning G., Nathan D.M., Grant R.W. Changes in glycemic control from 1996 to 2006 among adults with type 2 diabetes: a longitudinal cohort study. BMC Health Serv Res 2010, 158.
33. Bezie Y., Molina M., Hernandez N., Batista R., Niang S., Huet D. Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes. Diabetes Metab 2006, 6:611-616.
34. Monane M., Bohn R.L., Gurwitz J.H., Glynn R.J., Levin R., Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health 1996, 12:1805-1808.
35. Cramer J.A., Benedict A., Muszbek N., Keskinaslan A., Khan Z.M. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract 2008, 1:76-87.
36. Lerman I. Adherence to treatment: the key for avoiding long-term complications of diabetes. Arch Med Res 2005, 3:300-306.
37. Rhee M.K., Slocum W., Ziemer D.C., Culler S.D., Cook C.B., El-Kebbi I.M., et al. Patient adherence improves glycemic control. Diabetes Educ 2005, 2:240-250.
38. Kalantar-Zadeh K., Kopple J.D., Regidor D.L., Jing J., Shinaberger C.S., Aronovitz J., et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care 2007, 5:1049-1055.
39. Tahrani A.A., Bailey C.J., Del Prato S., Barnett A.H. Management of type 2 diabetes: new and future developments in treatment. Lancet 2011, 9786:182-197.